Personal Genome Diagnostics
Baltimore, US · Founded 1901 · 63 employees on LinkedIn · 6 known investors
A precision oncology company providing genomic testing and resources to support cancer care decisions, operating under Labcorp Oncology.
Investors · 6
Funding
SEC filings, press & company announcements- Undisclosed amountSeries BNov 2025Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Non-dilutive funding · 4 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2017 | $297.9K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2016 | $223K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2015 | $216.9K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2015 | $214.4K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does Personal Genome Diagnostics do?
- A precision oncology company providing genomic testing and resources to support cancer care decisions, operating under Labcorp Oncology.
- Who are Personal Genome Diagnostics's investors?
- Personal Genome Diagnostics's investors include 3B Future Health Fund, Catalio Capital Management, LP, Co-Win Ventures, New Enterprise Associates (NEA), Windham Capital Partners, Vensana Capital.
- Where is Personal Genome Diagnostics headquartered?
- Personal Genome Diagnostics is headquartered in Baltimore, US.